<code id='EE28119B6F'></code><style id='EE28119B6F'></style>
    • <acronym id='EE28119B6F'></acronym>
      <center id='EE28119B6F'><center id='EE28119B6F'><tfoot id='EE28119B6F'></tfoot></center><abbr id='EE28119B6F'><dir id='EE28119B6F'><tfoot id='EE28119B6F'></tfoot><noframes id='EE28119B6F'>

    • <optgroup id='EE28119B6F'><strike id='EE28119B6F'><sup id='EE28119B6F'></sup></strike><code id='EE28119B6F'></code></optgroup>
        1. <b id='EE28119B6F'><label id='EE28119B6F'><select id='EE28119B6F'><dt id='EE28119B6F'><span id='EE28119B6F'></span></dt></select></label></b><u id='EE28119B6F'></u>
          <i id='EE28119B6F'><strike id='EE28119B6F'><tt id='EE28119B6F'><pre id='EE28119B6F'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:6
          Zachary Kirimi inside a pharmacy -- health policy coverage from STAT
          Zachariah Kirimi is a pharmacist who uses the Maisha Meds app to help manage his inventory and offer subsidized products to patients. Courtesy Jack Hewson/Maisha Meds

          WASHINGTON — For an app that helps pharmacies in Africa manage their medicines, the term “pharmacy benefit manager” has become a dirty word.

          The organization, called Maisha Meds, plays the role of a middleman between international groups like USAID and the Gates Foundation and pharmacies. By definition, it’s a PBM. But since it’s a nonprofit company and it subsidizes medicines and tests aimed at promoting public health, it’s hesitant to describe itself that way.

          advertisement

          “Because so many people kind of think of PBMs in the U.S. as the enemy, we don’t ourselves use that term,” said Maisha Meds’ founder and CEO, Jessica Vernon.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          Life sciences investors close nearly $6 billion in new funds
          Life sciences investors close nearly $6 billion in new funds

          AdobeBiotechandlifesciencesinvestorscontinuetodrawinnewfundsevenasthebiotechstockindexesreachnewlows

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Being 'nonadherent' patient made me a more empathetic doctor

          AdobeWhenIwas13yearsold,Ihadtotake11pillseveryday.Ihadnon-Hodgkin’slymphoma,andthesepillsworkedeithe